Second Heart Assist concludes yet a third highly-successful trial in South America targeted at High Risk PCI that provides solid data on not only safety, but astounding results of efficacy (high-volume perfusion to kidneys, hemodynamic support, ultra-low hemolysis), and overall performance with ease of use with remarkable device deployment times that are stunning. https://www.prnewswire.com/news-releases/second-heart-assist-announces-the-conclusion-of-its-south-american-hrpci-study-with-exemplary-results-302326474.html?tc=eml_cleartime
Recent Posts
- Controlled Study Demonstrates Significantly Lower Hemolysis of Second Heart Assist Whisper Device Compared to J&J Impella
- Second Heart Assist’s “Whisper” speaks loudly to market needs
- Second Heart Assist Continues With Compelling Momentum and Data – Impressive Clinical Results
- Second Heart Assist Announces Impressive Successful Trials in Central America with its Whisperâ„¢ Device
- Latest Advances in Treatment of CHF with Devices